Monoolein-based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment.
Donida B, Tauffner B, Raabe M, Immich MF, de Farias MA, de Sá Coutinho D, Machado AZ, Kessler RG, Portugal RV, Bernardi A, Frozza R, Moura DJ, Poletto F, Vargas CR.
Donida B, et al.
Eur J Pharm Biopharm. 2018 Dec;133:96-103. doi: 10.1016/j.ejpb.2018.10.005. Epub 2018 Oct 10.
Eur J Pharm Biopharm. 2018.
PMID: 30315863